ESR1 Liquid Biopsy Test: Breast Cancer Hormone Resistance Marker and ctDNA Monitoring
An ESR1 liquid biopsy checks circulating tumor DNA (ctDNA) in blood for mutations in the gene that encodes estrogen receptor alpha. In estrogen receptor-positive,...
Exosome Cancer Test: Tumor RNA, Blood Biomarkers, and Diagnostic Research
An exosome cancer test analyzes tiny membrane-bound particles released by cells into blood or other body fluids for molecular clues associated with cancer. These...
FoundationOne Liquid CDx Test: ctDNA, Cancer Genomics, Mutation Report, and Companion Diagnostic Use
FoundationOne Liquid CDx is a blood-based comprehensive genomic profiling test used in people with solid tumors when a clinician needs information about cancer-related DNA...
Fragmentomics Cancer Blood Test: Cell-Free DNA Patterns and Early Detection Research
A fragmentomics cancer blood test looks at the physical patterns of cell-free DNA fragments in plasma rather than relying only on specific tumor mutations....
Galleri Test: Multi-Cancer Early Detection, Cancer Signal, and Result Meaning
The Galleri test is a prescription blood test designed to look for a shared cancer signal from many cancer types in people who do...
Guardant360 Test: Liquid Biopsy, Cancer Mutations, ctDNA, and Genomic Profiling
Guardant360 is a family of blood-based genomic profiling tests used mainly for people with advanced solid cancers. The current U.S. FDA-approved platform, Guardant360 Liquid...
KRAS Liquid Biopsy Test: Colon, Lung, Pancreatic Cancer, Mutation Status, and ctDNA Meaning
A KRAS liquid biopsy is a blood test that looks for tumor-derived KRAS mutations in circulating tumor DNA (ctDNA). It can help characterize some...
Liquid Biopsy Resistance Mutation Test: Cancer Drug Resistance Markers and Mutation Detection
A liquid biopsy resistance mutation test looks for genetic changes in circulating tumor DNA (ctDNA) that can explain why a cancer has stopped responding—or...
Liquid Biopsy Test: Circulating Tumor DNA, Blood-Based Tumor Testing, and Mutation Detection
A liquid biopsy is a laboratory test that looks for cancer-related material in blood or another body fluid instead of removing a piece of...
OncoBEAM Test: ctDNA Mutation Testing, Digital PCR, and Blood-Based Monitoring
OncoBEAM is a highly sensitive liquid-biopsy approach that uses BEAMing digital PCR to detect selected tumor mutations in circulating tumor DNA (ctDNA) from plasma....
RaDaR Test: ctDNA MRD, Cancer Monitoring, and Recurrence Detection
RaDaR is a personalized blood test that looks for tiny amounts of circulating tumor DNA (ctDNA) after a cancer has been treated or while...
Signatera Test: ctDNA MRD, Cancer Recurrence, and Personalized Monitoring
Signatera is a personalized circulating tumor DNA (ctDNA) blood test used to look for molecular residual disease (MRD) and to monitor cancer over time....
Tempus xF Test: Liquid Biopsy, Cancer Genomics, ctDNA, and Mutation Results
Tempus xF is a blood-based next-generation sequencing test that analyzes circulating tumor DNA (ctDNA) to look for genomic changes in solid cancers. Its main...
Tumor-Informed ctDNA Test: Personalized MRD Monitoring, Recurrence Detection, and Result Meaning
A tumor-informed ctDNA test is a personalized blood test built from genetic changes found in a patient’s own cancer. It is most often used...
Tumor-Naive ctDNA Test: Blood-Based Cancer Monitoring Without Tumor Tissue
A tumor-naive ctDNA test looks for cancer-related DNA signals in blood without first sequencing that patient’s tumor to build a custom assay. Also called...
ALK Test for Anaplastic Large Cell Lymphoma: Fusion Marker, Positive Result, and Tumor Classification
An ALK test helps determine whether an anaplastic large cell lymphoma (ALCL) belongs to the ALK-positive subtype, a biologically distinct form of systemic T-cell...
BCL2 Rearrangement Test: Follicular Lymphoma, Rearrangement Status, and FISH Result
A BCL2 rearrangement test looks for a structural change involving the BCL2 gene, most often the classic IGH::BCL2 fusion created by t(14;18)(q32;q21). This abnormality...
BCR-ABL1 Quantitative PCR Test: CML Monitoring, Molecular Response, and Transcript Level
The BCR-ABL1 quantitative PCR test is the main blood test used to monitor molecular response in chronic myeloid leukemia (CML). It measures the amount...
BCR-ABL1 Test: Chronic Myeloid Leukemia, Philadelphia Chromosome, and Molecular Diagnosis
A BCR-ABL1 test looks for the abnormal BCR::ABL1 fusion gene that defines chronic myeloid leukemia (CML) and can also occur in some acute leukemias....
Beta-2 Microglobulin Test for Myeloma: Staging, Prognosis, Tumor Burden, and Kidney Function
A beta-2 microglobulin test measures a small protein in blood that is used as part of staging and prognosis in multiple myeloma. In myeloma,...